By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
With the $40k difference between Doximity and Medscape, is this just sample size or perhaps a selection bias of respondents (academic vs private)? Are rheumatologists missing opportunities to increase their salary range and, if so, are there resources to help them identify and implement them?